The weekly litigation news digest is live. Subscribe now
Crastalline Hydrobromide Salt Of 5-Meo-Dmt - EP4313945
The patent EP4313945 was granted to GH Research Ireland on Mar 13, 2024. The application was originally filed on Mar 27, 2023 under application number EP23717046A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP4313945
- Application Number
- EP23717046A
- Filing Date
- Mar 27, 2023
- Status
- Granted And Under Opposition
- Feb 9, 2024
- Publication Date
- Mar 13, 2024
- External Links
- Slate, Register, Google Patents
Patent Summary
5-MeO-DMT hydrobromide, a crystalline acid addition salt of 5-MeO-DMT, exhibiting improved formulation characteristics. The salt has enhanced flow properties, stability, and solubility compared to conventional 5-MeO-DMT forms. It is particularly suitable for buccal or sublingual administration routes, offering a stable and pure salt form that maintains its pharmacological activity.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (9) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents